For the Inventor, By the Inventor

Enter assignee name

Vienna, Austria

Immuno Aktiengesellschaft

USPTO Granted Patents = 83

Trademarks = 1

Forward Citations = 1,598

Loading Chart...

Loading Chart...

81 inventors (with patents filed for the assignee):

Johann J Eibl (37 out of 101 patents)

Friedrich Dorner (28 out of 91 patents)

Peter Turecek (16 out of 118 patents)

4. Yendra Linnau (15 out of 39 patents)

5. Hans Peter Schwarz (15 out of 20 patents)

6. Hans-Peter Schwarz (11 out of 105 patents)

7. Wolfgang Mundt (11 out of 63 patents)

8. Artur Mitterer (10 out of 53 patents)

9. Bernhard Fischer (8 out of 62 patents)

10. Falko-Guenter Falkner (6 out of 17 patents)

11. Anton Philapitsch (6 out of 12 patents)

12. Manfred Reiter (5 out of 71 patents)

13. Noel Barrett (5 out of 19 patents)

14. Thomas Seelich (5 out of 16 patents)

15. Ludwig Pichler (5 out of 27 patents)

Core Competencies:

Von Willebrand Factor

Hybrid Proteins

Blood Coagulation Disorders

Pharmaceutical Preparations

Virus Inactivation

Recombinant Poxviruses

Thrombosis Agent

Influenza Virus Production

Tissue Adhesive

Immunoglobulin Preparation

Genomic DNA Quantitation

APC Response

83 patents: Sort by Forward Citations

1. 6103693 - Method for isolation of highly pure von willebrand factor (2000-08-15),

2. 6103244 - Methods for generating immune responses employing modified vaccinia of (2000-08-15),

3. 6100061 - Recombinant cell clone having increased stability in serum- and (2000-08-08),

4. 6051418 - Hybrid proteins with modified activity (2000-04-18),

5. 6005077 - Use of von willebrand factor and pharmaceutical formulation (1999-12-21),

6. 5962405 - Storage-stable fibrinogen preparations (1999-10-05),

7. 5910481 - Hybrid proteins with modified activity (1999-06-08),

8. 5892005 - High molecular and low molecular fractions of von willebrand factor (1999-04-06),

9. 5883078 - Hemostyptic and tissue adhesive (1999-03-16),

10. 5880265 - Method for isolation of highly pure von willebrand factor (1999-03-09),

11. 5877152 - Method for isolation of highly pure von Willebrand Factor (1999-03-02),

12. 5872099 - High molecular and low molecular fractions of von Willebrand Factor (1999-02-16),

13. 5869617 - High and low molecular weight fractions of von Willebrand Factor and (1999-02-09),

14. 5869292 - Hybrid proteins with modified activity (1999-02-09),

15. 5866122 - Pharmaceutical preparation for treating blood coagulation disorders (1999-02-02),

Immuno Aktiengesellschaft is a biotechnology company specializing in the development and production of innovative immunotherapies. With a focus on cancer treatments, we strive to improve patient outcomes and quality of life. Our team of experienced scientists and researchers work diligently to discover and develop groundbreaking therapies that harness the body's immune system to fight diseases. Visit our website to learn more about our cutting-edge research and ongoing clinical trials.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 9 2025

83 Patents

#7 in Vienna

#48 in Austria

#8,822 in the World

Vienna, Austria

Immuno Aktiengesellschaft

Forward Citations = 1,598

81 inventors:

Johann J Eibl (37 out of 101 patents)

Friedrich Dorner (28 out of 91 patents)

Peter Turecek (16 out of 118 patents)

4. Yendra Linnau (15 out of 39 patents)

5. Hans Peter Schwarz (15 out of 20 patents)

Please report any incorrect information to support@idiyas.com

Loading…